A new lawsuit against pharmaceutical company Boehringer Ingelheim has been added to the Pradaxa MDL in Illinois. The MDL consolidates more than 120 lawsuits filed by plaintiffs claiming that they suffered internal bleeding or other Pradaxa side effects after taking the anticoagulant drug. The Pradaxa... Read More

Pradaxa multidistrict litigation continues to progress in Illinois. Judge David R. Herndon, the U.S. District judge presiding over the federal MDL, has established guidelines for selecting bellwether trials from the hundreds of Pradaxa lawsuits currently pending in the coordination. These early trials will act as a type of... Read More

Plaintiff Kay Lanius joined Pradaxa litigation in the United States' District Court for the Middle District of Tennessee, Nashville, with her Pradaxa lawsuit, which she filed on October 19, 2012. The plaintiff has named Boehringer Ingelheim Pharmaceuticals, as well as Boehringer Ingelheim International, as defendants... Read More

As the Pradaxa lawsuits continue to pile up against Boehringer Ingelheim, the manufacturer of the drug, researchers and consumer watchdogs are taking a closer look at the medication. The latest organization to issue a warning about the potential for serious Pradaxa side effects is Public... Read More

Side effects of Pradaxa, including uncontrollable bleeding, heart attack, and death, have been a source of concern for some time. Now, another risk factor associated with the anticoagulant drug has been identified in a recent North Carolina study – an increased risk for some types... Read More

The Food and Drug Administration has published an editorial detailing the complications patients have encountered associated with the blood thinning medications Pradaxa and warfarin. Pradaxa is a relatively new medication that was marketed as a replacement to warfarin, which was the leading anticoagulant drug on... Read More

On March 26, 2013, a new complaint was filed against Boehringer Ingelheim Pharmaceuticals, Inc. regarding the blood-thinning medication, Pradaxa, which is manufactured by the defendants. The complaint was filed on behalf of Lisa R. Mulhall, the surviving daughter of Louise Newcomer, deceased. The decedent allegedly... Read More

The Food and Drug Administration recently released a report that showed that the bleeding risks of Pradaxa are comparable to the risks associated with a competing, older drug, known as warfarin. Many patients are skeptical of this report, as the Food and Drug Administration relied... Read More